日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Single, double, and triple-hit strategies to establish a long-term premature rabbit model of bronchopulmonary dysplasia

采用单次、两次和三次打击策略建立长期早产兔支气管肺发育不良模型

Catozzi, Chiara; Stretti, Francesca; Scalera, Enrica; Storti, Matteo; Modena, Angelo; Aquila, Giorgio; Villetti, Gino; Ferrini, Erica; Grandi, Andrea; Stellari, Franco Fabio; Ravanetti, Francesca; Ragionieri, Luisa; Ciccimarra, Roberta; Zoboli, Matteo; Brandenberger, Christina; Schulte, Henri; Murgia, Xabier; Civelli, Maurizio; Ricci, Francesca

Novel Cyclohexyl Amido Acid Antagonists of Lysophosphatidic Acid Type 1 Receptor for the Treatment of Pulmonary Fibrosis

新型环己基酰胺酸类溶血磷脂酸1型受体拮抗剂用于治疗肺纤维化

Giuliani, Marta; Rizzi, Andrea; Pagano, Mafalda; Raveglia, Luca F; Saccani, Francesca; Di Lascia, Maria Rosaria; Interlandi, Margherita; Nardella, Tonia Simona; Marchini, Gessica; Murgo, Annalisa; Tigli, Laura; Pappani, Alice; Capelli, Anna Maria; Fernandez, Sergio Xanxo; Puccini, Paola; Villetti, Gino; Civelli, Maurizio; Beato, Claudia; Moro, Elisa; Mundi, Claudia; Remelli, Rosaria; Armani, Elisabetta

Ophthalmate is a new regulator of motor functions via CaSR: implications for movement disorders

Ophthalmate 是一种通过 CaSR 调节运动功能的新型调节剂:对运动障碍的意义

Alhassen, Sammy; Hogenkamp, Derk; Nguyen, Hung Anh; Al Masri, Saeed; Abbott, Geoffrey W; Civelli, Olivier; Alachkar, Amal

Corrigendum: CHF6297: a novel potent and selective p38 MAPK inhibitor with robust anti-inflammatory activity and suitable for inhaled pulmonary administration as dry powder

更正:CHF6297:一种新型高效选择性p38 MAPK抑制剂,具有显著的抗炎活性,适用于干粉吸入给药。

Martucci, Cataldo; Allen, Andrew Dennis; Moretto, Nadia; Bagnacani, Valentina; Fioni, Alessandro; Patacchini, Riccardo; Civelli, Maurizio; Villetti, Gino; Facchinetti, Fabrizio

CHF6297: a novel potent and selective p38 MAPK inhibitor with robust anti-inflammatory activity and suitable for inhaled pulmonary administration as dry powder

CHF6297:一种新型强效选择性 p38 MAPK 抑制剂,具有强大的抗炎活性,适合以干粉形式吸入肺部给药

Cataldo Martucci, Andrew Dennis Allen, Nadia Moretto, Valentina Bagnacani, Alessandro Fioni, Riccardo Patacchini, Maurizio Civelli, Gino Villetti, Fabrizio Facchinetti

Micro-CT-assisted identification of the optimal time-window for antifibrotic treatment in a bleomycin mouse model of long-lasting pulmonary fibrosis.

利用微型CT辅助确定博来霉素诱导的长期肺纤维化小鼠模型中抗纤维化治疗的最佳时间窗口

Buccardi Martina, Grandi Andrea, Ferrini Erica, Buseghin Davide, Villetti Gino, Civelli Maurizio, Sverzellati Nicola, Aliverti Andrea, Pennati Francesca, Stellari Franco Fabio

Humanized dopamine D(4.7) receptor male mice display risk-taking behavior and deficits of social recognition and working memory in light/dark-dependent manner

人源化多巴胺D(4.7)受体雄性小鼠表现出冒险行为,并且在光照/黑暗条件下存在社交识别和工作记忆缺陷。

Alachkar, Amal; Phan, Alvin; Dabbous, Travis; Alhassen, Sammy; Alhassen, Wedad; Reynolds, Bryan; Rubinstein, Marcelo; Ferré, Sergi; Civelli, Olivier

Harnessing the translational power of bleomycin model: new insights to guide drug discovery for idiopathic pulmonary fibrosis

利用博来霉素模型转化医学的力量:为特发性肺纤维化药物研发提供新的见解

Murgo, Annalisa; Bignami, Fabio; Federico, Giuseppina; Villetti, Gino; Civelli, Maurizio; Sala, Angelo; Miglietta, Daniela

Editorial: Neuropeptide GPCRs in neuroendocrinology, Volume II

社论:神经内分泌学中的神经肽GPCR,第二卷

Vaudry, Hubert; Schoofs, Liliane; Civelli, Olivier; Kojima, Masayasu

Behavioral and neuro-functional consequences of eliminating the KCNQ3 GABA binding site in mice

消除小鼠 KCNQ3 GABA 结合位点对行为和神经功能的影响

Kiki J Chen, Ryan Yoshimura, Clarissa Adriana Edmundo, Tri Minh Truong, Olivier Civelli, Amal Alachkar, Geoffrey W Abbott